Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial-Reference-Cited by-同舟云学术

Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial

Published:2013-08 Issue:8 Volume:12 Page:747-755
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Schapira Anthony HV,McDermott Michael P,Barone Paolo,Comella Cynthia L,Albrecht Stefan,Hsu Helen H,Massey Daniel H,Mizuno Yoshikuni,Poewe Werner,Rascol Olivier,Marek Kenneth

Funder

Wellcome Trust/MRC Joint Call in Neurodegeneration award

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference29 articles.

1. Why have we failed to achieve neuroprotection in Parkinson's disease?;Olanow;Ann Neurol,2008

2. Neuroprotection trials in Parkinson's disease: systematic review;Hart;Mov Disord,2009

3. The Movement Disorder Society evidence-based medicine review update: treatments for the motor symptoms of Parkinson's disease;Fox;Mov Disord,2011

4. Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms;Gu;J Neurochem,2004

5. Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response;Iravani;Exp Neurol,2008

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dopamine agonists in the treatment of Parkinson's disease: the show must go on;Journal of Neural Transmission;2024-09-11

2. Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology;Journal of Neurology;2024-08-29

3. Does Delaying Levodopa Prevent Motor Complications in Parkinson's Disease? A Meta‐Analysis;Movement Disorders Clinical Practice;2024-08-27

4. Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson’s Disease;Brain Sciences;2024-07-31

5. Levodopa versus levodopa sparing in early parkinson�s disease: can we meet halfway?;Revista de investigaci�n Cl�nica;2024-07-12